Armbruster Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Armbruster Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$464K	Hold	926	–	–	0.07%	91
2026 Q1	$455K	Hold	926	–	–	0.07%	93
2025 Q4	$537K	Hold	926	–	–	0.09%	83
2025 Q3	$449K	Sell	926 -2	-0.2%	-$931	0.08%	93
2025 Q2	$376K	Buy	928 +2	+0.2%	+$836	0.07%	101
2025 Q1	$461K	Sell	926 -8	-0.9%	-$4.33K	0.09%	88
2024 Q4	$486K	Hold	934	–	–	0.1%	86
2024 Q3	$578K	Sell	934 -24	-3%	-$14.2K	0.12%	79
2024 Q2	$530K	Buy	958 +39	+4%	+$22.3K	0.11%	78
2024 Q1	$534K	Sell	919 -80	-8%	-$44.9K	0.11%	70
2023 Q4	$530K	Hold	999	–	–	0.12%	66
2023 Q3	$506K	Hold	999	–	–	0.13%	64
2023 Q2	$521K	Buy	999 +84	+9%	+$45.3K	0.13%	65
2023 Q1	$527K	Sell	915 -48	-5%	-$27.1K	0.13%	61
2022 Q4	$530K	Hold	963	–	–	0.14%	60
2022 Q3	$488K	Hold	963	–	–	0.14%	63
2022 Q2	$523K	Hold	963	–	–	0.14%	64
2022 Q1	$569K	Sell	963 -40	-4%	-$23K	0.14%	66
2021 Q4	$669K	Buy	1,003 +7	+0.7%	+$4.37K	0.15%	63
2021 Q3	$569K	Hold	996	–	–	0.16%	49
2021 Q2	$502K	Hold	996	–	–	0.14%	59
2021 Q1	$455K	Sell	996 -75	-7%	-$35.8K	0.13%	57
2020 Q4	$499K	Sell	1,071 -50	-4%	-$23.4K	0.17%	48
2020 Q3	$495K	Sell	1,121 -37	-3%	-$15.3K	0.19%	45
2020 Q2	$420K	Hold	1,158	–	–	0.17%	48
2020 Q1	$328K	Sell	1,158 -146	-11%	-$46K	0.15%	58
2019 Q4	$424K	Hold	1,304	–	–	0.16%	51
2019 Q3	$380K	Sell	1,304 -10	-0.8%	-$2.86K	0.16%	54
2019 Q2	$386K	Sell	1,314 -155	-11%	-$42.7K	0.16%	52
2019 Q1	$402K	Hold	1,469	–	–	0.17%	49
2018 Q4	$329K	Buy	1,469 +106	+8%	+$24.9K	0.16%	52
2018 Q3	$333K	Hold	1,363	–	–	0.15%	55
2018 Q2	$282K	Hold	1,363	–	–	0.13%	55
2018 Q1	$281K	Hold	1,363	–	–	0.13%	52
2017 Q4	$259K	Hold	1,363	–	–	0.12%	55
2017 Q3	$258K	Hold	1,363	–	–	0.13%	51
2017 Q2	$238K	Hold	1,363	–	–	0.13%	55
2017 Q1	$209K	Hold	1,363	–	–	0.12%	58
2016 Q4	$192K	Hold	1,363	–	–	0.11%	64
2016 Q3	$217K	Hold	1,363	–	–	0.13%	58
2016 Q2	$201K	Hold	1,363	–	–	0.13%	67
2016 Q1	$193K	Hold	1,363	–	–	0.13%	66
2015 Q4	$193K	Buy	+1,363	New	+$182K	0.17%	67

Other funds holding TMO

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Armbruster Capital Management's TMO Position: Q2 2026 in Review

Armbruster Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 926 shares worth $464K. The position accounts for 0.07% of the portfolio, ranked #91.

Armbruster Capital Management first reported a position in TMO in Q4 2015 and has held it in 43 quarters since. The position peaked at $669K in Q4 2021. 500 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Armbruster Capital Management held 926 shares of Thermo Fisher Scientific worth $464K as of Q2 2026.
Armbruster Capital Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
Thermo Fisher Scientific made up 0.07% of Armbruster Capital Management's portfolio in Q2 2026, its #91 holding.
Armbruster Capital Management first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 43 quarters since.
Armbruster Capital Management's Thermo Fisher Scientific position peaked at $669K in Q4 2021.
500 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Armbruster Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.